Health Care Equipment

ZYNEX INC

SEC Ends Investigation of Zynex Without Enforcement Action

Zynex and Humana Reach Supplier Agreement

Zynex, Inc. to Focus on Developing and Selling Non-Invasive Medical Tools

Zynex Responds to Federal Suit Against Former Executives and Undertakes Leadership Reorganization

Zynex Inc. Secures $22.3 Million Debtor-in-Possession Loan

ZYXIQ.US released FY2025 Q3 earnings on November 17 (BJT), actual revenue USD 13.36 M (forecast USD 24.53 M), actual EPS USD -1.42

ZYNEX INC released FY2025 9 Months Earnings on November 17, 2025 (EST) with actual revenue of USD 62.23 M and EPS of USD -2.412

ZYNEX INC released FY2024 9 Months Earnings on November 17, 2025 (EST) with actual revenue of USD 146.38 M and EPS of USD 0.1086

Zynex Inc. released FY2024 Q3 earnings on November 17 (EST), actual revenue USD 49.97 M (forecast USD 50.83 M), actual EPS USD 0.07

Zynex Inc. released FY2024 Q2 earnings on July 31 (EST), actual revenue USD 49.88 M (forecast USD 52.09 M), actual EPS USD 0.0383

Zynex Inc. released FY2025 Semi-Annual Earnings on July 31 (EST), with actual revenue of USD 48.87 M and EPS of USD -0.9838

Zynex Inc. released FY2024 Semi-Annual Earnings on July 31 (EST), with actual revenue of USD 96.41 M and EPS of USD 0.0382

Zynex Inc. released FY2025 Q2 earnings on July 31 (EST), actual revenue USD 22.29 M (forecast USD 27.38 M), actual EPS USD -0.662

Zynex Inc. released FY2025 Q1 earnings on April 29 (EST), actual revenue USD 26.58 M (forecast USD 30.75 M), actual EPS USD -0.33

Zynex Inc. released FY2024 Q1 earnings on April 29 (EST), actual revenue USD 46.53 M (forecast USD 47.69 M), actual EPS USD 0.0003

ZYNEX INC released FY2024 Q4 earnings on March 11 (EST), actual revenue USD 45.97 M (forecast USD 53.65 M), actual EPS USD -0.0202

ZYXIQ.US released FY2023 Annual Earnings on March 11 (BJT), actual revenue USD 184.32 M (forecast USD 191.64 M), actual EPS USD 0.27

Zynex Inc. released FY2023 Q4 earnings on March 11 (EST), actual revenue USD 47.29 M (forecast USD 55.62 M), actual EPS USD 0.0361

ZYNEX INC released FY2024 earnings on March 11 (EST), actual revenue USD 192.35 M (forecast USD 200.04 M), actual EPS USD 0.09

Paranovus ENT Tech

Robin Energy - WI

ENvue Medical

Fundrise Innovation Fund LLC

CVD Equipment

T-REX 2X Inverse CRCL Daily Target ETF

Swarmer

AleAnna

Sol-Gel Tech

DRUGS MADE IN AMERICA ACQ II CORP ORD USD0.0001 (SUBS/RTS) 16/09/2030

Delcath

雅培

直觉外科

史赛克

波士顿科学

爱德华生命科学

IDEXX实验室

瑞思迈

德康医疗

STERIS

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

ZYNEX INC(ZYXIQ.US)

ZYNEX INC Stock Performance Chart